NSE filing, NSE: BANKA. Summary written from the filing by ALFA Finder's alert engine.
Banka Bioloo Ltd: key numbers
- Share price
- ₹62.16
- Market cap
- ₹67.98 Cr
- Revenue (annual)
- ₹57.09 Cr
- Net profit (annual)
- ₹0.35 Cr
- P/E (TTM)
- 204.2×Sector 21.0×
- Promoter holding
- 52.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Banka Bioloo Ltd
All →Banka Bioloo Investor Presentation: Key Takeaways
Banka Bio reported FY26 total income of ₹58.4 cr (+7.1% YoY) and a return to profitability with ₹0.39 cr PAT. Strategy focuses on converting Megaliter's asset-light contracted revenues into recurring cash flows.
Banka Bioloo Annual General Meeting
Banka BioLoo Limited conducted its 14th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement adoption and director re-appointment.
Banka Bioloo Annual General Meeting
Banka BioLoo Limited has issued the notice for its 14th Annual General Meeting, scheduled to be held on September 17, 2026, via video conferencing.
Banka Bioloo Investor Presentation: Key Takeaways
Banka BioLoo reported strong Q1 FY27 growth with Revenue up 20.5% and PAT surging 162.3% YoY. The company is scaling its water infrastructure portfolio through subsidiary Megaliter Varunaa.
Banka Bioloo Q1 FY27 Results: Net Profit ₹0 Cr
Banka Bioloo Ltd reported revenue from operations of ₹10.6 Cr (-4.5% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Banka Bioloo Employee Stock Options
Banka BioLoo Limited announced the grant of 16,000 options to eligible employees under its existing 2023 Employee Stock Option Plan.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date